Probiotics for preventing ventilator-associated pneumonia

Medicine & Life Sciences

• Anti-Bacterial Agents 7%
• Artificial Respiration 5%
• Bifidobacterium longum 8%
• Chlorhexidine 6%
• Confidence Intervals 29%
• Control Groups 2%
• Cross Infection 5%
• Data Analysis 4%
• Diarrhea 9%
• Glutamine 5%
• Hospital Mortality 10%
• Incidence 13%
• Intensive Care Units 27%
• Intention to Treat Analysis 6%
• Lactobacillus casei 7%
• Lactobacillus delbrueckii 8%
• Lactobacillus plantarum 7%
• Lactobacillus rhamnosus 7%
• MEDLINE 4%
• Meta-Analysis 4%
• Mortality 2%
• Odds Ratio 17%
• Patient Selection 4%
• Peptides 3%
• Placebos 7%
• Probiotics 83%
• Randomized Controlled Trials 15%
• Risk Assessment 4%
• Safety 6%
• Sample Size 4%
• Streptococcus thermophilus 8%
• Synbiotics 8%
• Uncertainty 5%
• Ventilator-Associated Pneumonia 100%